At the recent AGM we were privileged to have senior executives of Mitsubishi present.
They were there to get a closer look at the board and quality of share holder. They were not disappointed.
At the time the sign off agreement with Mitsubishi was super close. Mitsubishi were to release the other $14,000,000 USD on signing.
However Jim and the board picked up a further $7-800,000 from the options take up. Enough to do further site works and get ready for the big play in 2015
The big change since then has been the fall of the $A v $US, so in the mix it appears CNQ have picked up another A$1.68m just waiting.
I say Jim forget the tungsten we are making out like bandits doing little.
The extra funds will enable faster expansion into the main pit and increase the overall viability of CNQ.
In conclusion a merry Christmas and a .45c new year to all the CNQ user group. And to U too Jim.
- Forums
- ASX - By Stock
- EQR
- Jim plays the long game
Jim plays the long game
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EQR (ASX) to my watchlist
|
|||||
Last
4.8¢ |
Change
0.001(2.13%) |
Mkt cap ! $99.13M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.8¢ | $18.90K | 393.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.047 |
1 | 124131 | 0.046 |
2 | 634000 | 0.045 |
1 | 2275 | 0.044 |
3 | 306558 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 50000 | 1 |
0.049 | 192376 | 4 |
0.050 | 275000 | 3 |
0.051 | 25000 | 2 |
0.065 | 287904 | 1 |
Last trade - 15.31pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
EQR (ASX) Chart |